Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: A systematic review and meta-analysis

International Journal of Clinical Practice

Volumn 69, Issue 9, 2015, Pages 998-1006

  Thongprayoon, C ^a   Cheungpasitporn, W ^a   Phatharacharukul, P ^b   Edmonds, P J ^c   Kaewpoowat, Q ^d   Mahaparn, P ^e   Bruminhent, J ^f   Erickson, S B ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; END STAGE RENAL DISEASE; MORTALITY; PATIENT ASSESSMENT; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; CHRONIC KIDNEY FAILURE; CLOSTRIDIUM INFECTION; COMPLICATION; CROSS INFECTION; HOSPITALIZATION; HUMAN; META ANALYSIS; MICROBIOLOGY; STATISTICS AND NUMERICAL DATA;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84940452675     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12672     Document Type: Review

References (40)

1. Magill SS, Edwards JR, Bamberg W, et al., et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014; 370: 1198-208.
2. Lessa FC, Gould CV, McDonald LC,. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis 2012; 55 (Suppl. 2): S65-70.
3. McDonald LC, Owings M, Jernigan DB,. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
4. Redelings MD, Sorvillo F, Mascola L,. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13: 1417-9.
5. Burckhardt F, Friedrich A, Beier D, Eckmanns T,. Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008; 14: 691-2.
6. Gravel D, Miller M, Simor A, et al., et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48: 568-76.
7. Minino AM, Xu J, Kochanek KD,. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010; 59: 1-52.
8. Abou Chakra CN, Pepin J, Sirard S, Valiquette L,. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS ONE 2014; 9: e98400.
9. Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, Mahaparn P, Bruminhent J,. High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: a Systematic Review and Meta-analysis. J Nat Sci 2015; 1: e85.
10. (CDC) CfDCaP. National Chronic Kidney Disease Fact Sheet: general information and national estimates on chronic kidney disease in the United States, 2014. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2014.
11. Jha V, Garcia-Garcia G, Iseki K, et al., Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-72.
12. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Kittanamongkolchai W, Erickson SB,. Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis. Nephrology 2014; 19: 791-7.
13. Yousuf K, Saklayen MG, Markert RJ, Barde CJ, Gopalswamy N,. Clostridium difficile-associated diarrhea and chronic renal insufficiency. South Med J 2002; 95: 681-3.
14. Dudukgian H, Sie E, Gonzalez-Ruiz C, Etzioni DA, Kaiser AM.,. C. difficile colitis-predictors of fatal outcome. J Gastrointest Surg 2010; 14: 315-22.
15. Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB,. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect 2011; 79: 359-63.
16. Halabi WJ, Nguyen VQ, Carmichael JC, Pigazzi A, Stamos MJ, Mills S,. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Am Coll Surg 2013; 217: 802-12.
17. Lee DY, Chung EL, Guend H, Whelan RL, Wedderburn RV, Rose KM,. Predictors of mortality after emergency colectomy for Clostridium difficile colitis: an analysis of ACS-NSQIP. Ann Surg 2014; 259: 148-56.
18. Pant C, Deshpande A, Anderson MP, Sferra TJ,. Clostridium difficile infection is associated with poor outcomes in end-stage renal disease. J Investig Med 2012; 60: 529-32.
19. Cunney RJ, Magee C, McNamara E, Smyth EG, Walshe J,. Clostridium difficile colitis associated with chronic renal failure. Nephrol Dial Transplant 1998; 13: 2842-6.
20. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE,. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg 2002; 137: 1096-100.
21. Mullane KM, Cornely OA, Crook DW, et al., Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials. Am J Nephrol 2013; 38: 1-11.
22. Wilson V, Cheek L, Satta G, et al., Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010; 50: e77-81.
23. Pepin J, Vo TT, Boutros M, et al., Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009; 52: 400-5.
24. Stewart DB, Hollenbeak CS,. Clostridium difficile colitis: factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg 2011; 15: 1548-55.
25. Jadad AR, Moore RA, Carroll D, et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
26. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
27. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
29. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR,. Publication bias in clinical research. Lancet 1991; 337: 867-72.
30. Do AN, Fridkin SK, Yechouron A, et al., Risk factors for early recurrent Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26: 954-9.
31. Henrich TJ, Krakower D, Bitton A, Yokoe DS,. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009; 15: 415-22.
32. Fujitani S, George WL, Murthy AR,. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32: 220-8.
33. Bauer MP, Notermans DW, van Benthem BH, et al., Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63-73.
34. Manek K, Williams V, Callery S, Daneman N,. Reducing the risk of severe complications among patients with Clostridium difficile infection. Can J Gastroenterol 2011; 25: 368-72.
35. Rouleau JL, Warnica WJ, Baillot R, et al., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008; 117: 24-31.
36. Kim YG, Graham DY, Jang BI,. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol 2012; 46: 397-400.
37. Pardi DS,. Recurrent Clostridium difficile infection: an immunodeficiency state? Clin Gastroenterol Hepatol 2007; 5: 672-3.
38. Betjes MG,. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 2013; 9: 255-65.
39. Johnson S,. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009; 58: 403-10.
40. Keddis MT, Khanna S, Noheria A, Baddour LM, Pardi DS, Qian Q,. Clostridium difficile infection in patients with chronic kidney disease. Mayo Clin Proc 2012; 87: 1046-53.